Effect of Acetylcysteine Solution Atomization Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease
Objective:To investigate the clinical efficacy of acetylcysteine solution atomization inhalation therapy in patients with chronic obstructive pulmonary disease(COPD)and its effect on immune function,lung function and quality of life.Methods:Eighty-two patients with COPD diagnosed and treated in our hospital from September 2021 to September 2022 were selected and randomly divided into conventional treatment group and combination treatment group,with 41 patients in each group.The control group was given routine therapy,and the combined therapy group was given aerosol inhalation of 3ml acetylcysteine solution on the basis of the control group.The clinical treatment effect,serum inflammatory factors,immune function,pulmonary function,quality of life score and exercise tolerance were compared between the two groups.Results:The total effective rate of clinical treatment in the combined treatment group was higher than that in the conventional treatment group(P<0.05).The levels of TNF-α,IL-6 and IL-8 in the combined treatment group were lower than those in the conventional treatment group(P<0.05).The levels of FVC,FEV1,FEV1/FVC and PEF in the combined treatment group were higher than those in the conventional treatment group(P<0.05).The values of CD3+,CD4+and CD4+/CD8+in the combined treatment group were higher than those in the conventional treatment group,and the value of CD8+was lower than that in the conventional treatment group(P<0.05).The SGRQ score of the combined treatment group was lower than that of the conventional treatment group,and the 6MWT was higher than that of the conventional treatment group(P<0.05).Conclusion:Acetylcysteine solution atomization inhalation therapy has positive significance for improving the total effective rate of clinical treatment of COPD patients,improving the immune function and lung function of patients,and is worthy of clinical application.
AcetylcysteineChronic obstructive pulmonary diseaseClinical efficacyImmune functionLung functionQuality of life